Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective
Henningfield, Jack E, Ashworth, Judy, Heal, David J, Smith, Sharon L
Published in Journal of psychopharmacology (Oxford) (01.01.2023)
Published in Journal of psychopharmacology (Oxford) (01.01.2023)
Get more information
Journal Article
Kratom Abuse Potential 2021: An Updated Eight Factor Analysis
Henningfield, Jack E, Wang, Daniel W, Huestis, Marilyn A
Published in Frontiers in pharmacology (28.01.2022)
Published in Frontiers in pharmacology (28.01.2022)
Get full text
Journal Article
Understanding Kratom Use: A Guide for Healthcare Providers
Swogger, Marc T, Smith, Kirsten E, Garcia-Romeu, Albert, Grundmann, Oliver, Veltri, Charles A, Henningfield, Jack E, Busch, Lorna Y
Published in Frontiers in pharmacology (02.03.2022)
Published in Frontiers in pharmacology (02.03.2022)
Get full text
Journal Article
A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor
Carter, Lawrence P, Henningfield, Jack E, Wang, Y Grace, Lu, Yuan, Kelsh, Debra, Vince, Bradley, Sellers, Edward
Published in Journal of psychopharmacology (Oxford) (01.12.2018)
Published in Journal of psychopharmacology (Oxford) (01.12.2018)
Get full text
Journal Article
The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users
Shram, Megan J., Henningfield, Jack E., Apseloff, Glen, Gorodetzky, Charles W., De Martin, Sara, Vocci, Frank L., Sapienza, Frank L., Kosten, Thomas R., Huston, Jeff, Buchhalter, August, Ashworth, Judy, Lanier, Ryan, Folli, Franco, Mattarei, Andrea, Guidetti, Clotilde, Comai, Stefano, O’Gorman, Cedric, Traversa, Sergio, Inturrisi, Charles E., Manfredi, Paolo L., Pappagallo, Marco
Published in Translational psychiatry (07.06.2023)
Published in Translational psychiatry (07.06.2023)
Get full text
Journal Article
Evaluation of the abuse potential of difelikefalin, a selective kappa‐opioid receptor agonist, in recreational polydrug users
Shram, Megan J., Spencer, Robert H., Qian, Jenny, Munera, Catherine L., Lewis, Michael E., Henningfield, Jack E., Webster, Lynn, Menzaghi, Frédérique
Published in Clinical and translational science (01.02.2022)
Published in Clinical and translational science (01.02.2022)
Get full text
Journal Article
Advancing equity, diversity, and inclusion in the American College of Neuropsychopharmacology (ACNP): advances, challenges, and opportunities to accelerate progress
Henningfield, Jack E, Fields, Sherecce, Anthony, James C, Brown, Jr, Lawrence S, Bolaños-Guzmán, Carlos A, Comer, Sandra D, De La Garza, 2nd, Richard, Furr-Holden, Debra, Garcia-Romeu, Albert, Hatsukami, Dorothy K, Raznahan, Armin, Zarate, Carlos A
Published in Neuropsychopharmacology (New York, N.Y.) (01.04.2021)
Published in Neuropsychopharmacology (New York, N.Y.) (01.04.2021)
Get full text
Journal Article
Pain management strategies and lessons from the military: A narrative review
Vallerand, April Hazard, Cosler, Patricia, Henningfield, Jack E, Galassini, Pam
Published in Pain research & management (01.09.2015)
Published in Pain research & management (01.09.2015)
Get full text
Journal Article
Abuse Liability Assessment of Tobacco Products Including Potential Reduced Exposure Products
Carter, Lawrence P, Stitzer, Maxine L, Henningfield, Jack E, O'Connor, Rich J, Cummings, K Michael, Hatsukami, Dorothy K
Published in Cancer epidemiology, biomarkers & prevention (01.12.2009)
Published in Cancer epidemiology, biomarkers & prevention (01.12.2009)
Get full text
Journal Article
Reply to Drs. Hart and Cadet: we agree-the challenges of increasing equity, diversity and inclusion include societal issues and actions now are vital
Henningfield, Jack E, Fields, Sherecce, Anthony, James C, Brown, Jr, Lawrence S, Bolaños-Guzmán, Carlos A, Comer, Sandra D, De La Garza, 2nd, Richard, Furr-Holden, Debra, Garcia-Romeu, Albert, Hatsukami, Dorothy, Raznahan, Armin, Zarate, Jr, Carlos A
Published in Neuropsychopharmacology (New York, N.Y.) (01.04.2021)
Published in Neuropsychopharmacology (New York, N.Y.) (01.04.2021)
Get full text
Journal Article
Kratom withdrawal: Discussions and conclusions of a scientific expert forum
Henningfield, Jack E., Chawarski, Marek C., Garcia-Romeu, Albert, Grundmann, Oliver, Harun, Norsyifa, Hassan, Zurina, McCurdy, Christopher R., McMahon, Lance R., Sharma, Abhisheak, Shoaib, Mohammed, Singh, Darshan, Smith, Kirsten E., Swogger, Marc T., Vicknasingam, Balasingam, Walsh, Zachary, Wang, Daniel W., Huestis, Marilyn A.
Published in Drug and alcohol dependence reports (01.06.2023)
Published in Drug and alcohol dependence reports (01.06.2023)
Get full text
Journal Article
Current and Future Potential Impact of COVID-19 on Kratom ( Mitragyna speciosa Korth.) Supply and Use
Singh, Darshan, Brown, Paula N, Cinosi, Eduardo, Corazza, Ornella, Henningfield, Jack E, Garcia-Romeu, Albert, McCurdy, Christopher R, McMahon, Lance R, Prozialeck, Walter C, Smith, Kirsten E, Swogger, Marc T, Veltri, Charles, Walsh, Zach, Grundmann, Oliver
Published in Frontiers in psychiatry (26.11.2020)
Published in Frontiers in psychiatry (26.11.2020)
Get full text
Journal Article
The abuse potential of lemborexant, a dual orexin receptor antagonist, according to the 8 factors of the Controlled Substances Act
Moline, Margaret, Asakura, Shoji, Beuckman, Carsten, Landry, Ishani, Setnik, Beatrice, Ashworth, Judy, Henningfield, Jack E.
Published in Psychopharmacology (01.04.2023)
Published in Psychopharmacology (01.04.2023)
Get full text
Journal Article
We Need Better Estimates of Kratom Use Prevalence
Henningfield, Jack E, Grundmann, Oliver, Garcia-Romeu, Albert, Swogger, Marc T
Published in American journal of preventive medicine (01.01.2022)
Published in American journal of preventive medicine (01.01.2022)
Get full text
Journal Article